Phase 3 trial of Russia’s Sputnik V vaccine against Covid-19 is continuing, Health Ministry says in text message.
- Supplies of vaccine are adequate for the trial to continue, RIA Novosti reports, citing Alexander Gintsburg, director of the Gamaleya Institute, developer of the inoculation
- Trial on track to reach target of 40,000 subjects, Health Ministry says, according to RIA
- Trials continuing, reports of suspension due to shortage are false, says Alexey Butylin, managing director of Crocus Medical, research organization that’s working with Gamaleya on vaccine trial
Russia Covid Vaccine Trial Paused Due to Dose Shortage: Reuters
To contact the reporters ...